MENU

ACRV Acrivon Therapeutics Forecast, Technical & Fundamental Analysis

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

ACRV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ACRV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 62.79% to -69 cents per share on November 12

Acrivon Therapeutics ACRV Stock Earnings Reports
Q3'26
Est.
$-0.70
Q2'26
Beat
by $0.21
Q1'26
Beat
by $0.13
Q4'25
Beat
by $0.72
Q3'25
Beat
by $0.69
The last earnings report on August 12 showed earnings per share of -43 cents, beating the estimate of -63 cents. With 91.85K shares outstanding, the current market capitalization sits at 88.28M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
76
Web
https://www.acrivon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MVFD30.330.37
+1.24%
Monarch Volume Factor Dividend Tree ETF (MVFD)
TMFX23.730.17
+0.71%
Motley Fool Next Index ETF (TMFX)
VLLU27.01N/A
N/A
AlphaEdge Large Cap Value ETF
DUBS42.85-0.01
-0.01%
Aptus Large Cap Enhanced Yield ETF (DUBS)
CRUX28.50-0.05
-0.16%
Columbia Core Bond ETF (CRUX)

ACRV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-1.95%
ALLR - ACRV
48%
Loosely correlated
-0.95%
IMRX - ACRV
44%
Loosely correlated
-1.59%
CRMD - ACRV
43%
Loosely correlated
-3.64%
DNA - ACRV
41%
Loosely correlated
-2.57%
ABSI - ACRV
36%
Loosely correlated
-0.19%
More
Acrivon Therapeutics (ACRV) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com